Burkhard Hinz

6.4k total citations
129 papers, 5.0k citations indexed

About

Burkhard Hinz is a scholar working on Pharmacology, Molecular Biology and Surgery. According to data from OpenAlex, Burkhard Hinz has authored 129 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pharmacology, 40 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Burkhard Hinz's work include Cannabis and Cannabinoid Research (45 papers), Inflammatory mediators and NSAID effects (39 papers) and Pancreatic function and diabetes (16 papers). Burkhard Hinz is often cited by papers focused on Cannabis and Cannabinoid Research (45 papers), Inflammatory mediators and NSAID effects (39 papers) and Pancreatic function and diabetes (16 papers). Burkhard Hinz collaborates with scholars based in Germany, Austria and United States. Burkhard Hinz's co-authors include Kay Brune, Robert Ramer, Andreas Pahl, Jutta Merkord, R Hirschelmann, Michael Linnebacher, Maria Haustein, Bertold Renner, Achim Salamon and Kay Brune and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and Scientific Reports.

In The Last Decade

Burkhard Hinz

126 papers receiving 4.8k citations

Peers

Countries citing papers authored by Burkhard Hinz

Since Specialization

Citations

This map shows the geographic impact of Burkhard Hinz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Hinz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Hinz more than expected).

Fields of papers citing papers by Burkhard Hinz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Hinz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Hinz. The network helps show where Burkhard Hinz may publish in the future.

Co-authorship network of co-authors of Burkhard Hinz

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard Hinz. A scholar is included among the top collaborators of Burkhard Hinz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard Hinz. Burkhard Hinz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anandamide Inhibits Vascular Smooth Muscle Migration, Endothelial Adhesion Protein Expression and Monocyte Adhesion of Human Coronary Artery Cells 2024 ·Cells ·(unknown), (unknown), Burkhard Hinz	1
2	Computational identification of natural senotherapeutic compounds that mimic dasatinib based on gene expression data 2024 ·Scientific Reports ·(unknown), Burkhard Hinz, Lars Boeckmann, (unknown), (unknown), Lars Kuepfer, Georg Fuellen, Israel Barrantes	12
3	β-Caryophyllene Inhibits Endothelial Tube Formation by Modulating the Secretome of Hypoxic Lung Cancer Cells—Possible Role of VEGF Downregulation 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Sander Bekeschus, Robert Ramer, Burkhard Hinz	6
4	Inhibition of Monoacylglycerol Lipase Decreases Angiogenic Features of Endothelial Cells via Release of Tissue Inhibitor of Metalloproteinase-1 from Lung Cancer Cells 2023 ·Cells ·(unknown), (unknown), (unknown), Jutta Merkord, Robert Ramer, Burkhard Hinz	4
5	A Thia-Analogous Indirubin N-Glycoside Disrupts Mitochondrial Function and Causes the Death of Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells 2023 ·Cells ·(unknown), (unknown), Anne Rupprecht, Robert Ramer, Peter Langer, Steffen Emmert, Marcus Frank, Burkhard Hinz	2
6	Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells 2023 ·Cells ·(unknown), (unknown), (unknown), Sander Bekeschus, Robert Ramer, Burkhard Hinz	2
7	Effect of Flavonoids on MCP-1 Expression in Human Coronary Artery Endothelial Cells and Impact on MCP-1-Dependent Migration of Human Monocytes 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Burkhard Hinz	5
8	The role of acetylsalicylic acid in the prevention of pre-eclampsia, fetal growth restriction, and preterm birth 2023 ·Deutsches Ärzteblatt international ·Johannes Stubert, Burkhard Hinz, Richard E. Berger	2
9	The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB1 Cannabinoid Receptor 2021 ·Molecular Cancer Therapeutics ·(unknown), Robert Ramer, (unknown), Igor Ivanov, Jutta Merkord, Burkhard Hinz	27
10	Cannabinoid-Induced Autophagy and Heme Oxygenase-1 Determine the Fate of Adipose Tissue-Derived Mesenchymal Stem Cells under Stressful Conditions 2020 ·Cells ·(unknown), (unknown), Kirsten Peters, Burkhard Hinz	8
11	A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells 2014 ·Analytical and Bioanalytical Chemistry ·Igor Ivanov, (unknown), Burkhard Hinz	21
12	Paracetamol and cyclooxygenase inhibition: is there a cause for concern? 2011 ·Annals of the Rheumatic Diseases ·Burkhard Hinz, Kay Brune	86
13	Synthesis of Thia‐Analogous Indirubin N‐Glycosides and their Influence on Melanoma Cell Growth and Apoptosis 2010 ·ChemMedChem ·Manfred Kunz, Katrin Marie Driller, Martin Hein, (unknown), (unknown), Robert Ramer, Burkhard Hinz, Anja Berger, Jürgen Eberle, Peter Langer	24
14	Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells 2010 ·Pharmaceutical Research ·Robert Ramer, (unknown), Jutta Merkord, (unknown), Burkhard Hinz	77
15	Bioequivalence study of low-dose diclofenac potassium tablet formulations 2009 ·International Journal of Clinical Pharmacology and Therapeutics ·Burkhard Hinz, (unknown), Grigorios Fotopoulos, Michael S. Gold	5
16	Antitumorigenic Effects of Cannabinoids beyond Apoptosis 2009 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Robert Ramer, Burkhard Hinz	62
17	Valdecoxib does not interfere with the CYP2D6 substrate metoprolol 2006 ·International Journal of Clinical Pharmacology and Therapeutics ·Ulrike Werner, Constanze Lamprecht, Dierk Werner, Simon Schaefer, H Wuttke, Burkhard Hinz, Martin F. Fromm, Kay Brune	2
18	More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib 2005 ·Arthritis & Rheumatism ·Burkhard Hinz, Harald Dormann, Kay Brune	41
19	Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated Human Monocytes Is Modulated by Cyclic AMP, Prostaglandin E2, and Nonsteroidal Anti-inflammatory Drugs 2000 ·Biochemical and Biophysical Research Communications ·Burkhard Hinz, Kay Brune, Andreas Pahl	71
20	COX‐1 und COX‐2: Funktionen und pharmakologische Beeinflussung 1999 ·Pharmazie in unserer Zeit ·Burkhard Hinz, Kay Brune	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact